PRECIGEN, INC. — Director's Dealing 2020

Jan 7, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTREXON CORP (XON)
CIK: 0001356090
Period of Report: 2020-01-04

Reporting Person: Sabzevari Helen (President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-04	Common Stock	M	17667	—	Acquired	104734	Direct
2020-01-06	Common Stock	S	6732	$5.8293	Disposed	98002	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-04	Restricted Stock Units	$	M	17667	Disposed		Common Stock (17667)	Direct
2020-01-05	Restricted Stock Units	$	A	500000	Acquired		Common Stock (500000)	Direct
2020-01-05	Option to Purchase Common Stock (Right to Buy)	$5.95	A	1500000	Acquired	2030-01-05	Common Stock (1500000)	Direct
2020-01-05	Option to Purchase Common Stock (Right to Buy)	$11.90	A	1500000	Acquired	2030-01-05	Common Stock (1500000)	Direct
2020-01-05	Option to Purchase Common Stock (Right to Buy)	$17.85	A	1500000	Acquired	2030-01-05	Common Stock (1500000)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of XON common stock.

F2: This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.

F3: The restricted stock units were granted on January 4, 2019 and January 25, 2019, and the remaining restricted stock units vest in three equal annual installments on each of January 4, 2021, 2022, and 2023.

F4: The restricted stock units vest in full on January 5, 2021.

F5: The option vests in four installments as follows: 50% on January 5, 2021, and the remaining 50% in three equal annual installments on each of January 5, 2022, 2023, and 2024.

F6: The option vests in four equal annual installments beginning on January 5, 2021.